pdf, 1996K - WestLB

Trend Information:
Management Information:
Use of Proceeds:
There has been no material adverse change in the prospects of WestLB or
WestLB Group since 31st December, 2005.
Management of WestLB is carried out by the Managing Board which is
comprised of the following members:
Dr. Thomas R. Fischer, Chairman of the Managing Board
Dr. Norbert Emmerich, Vice Chairman of the Managing Board
Dr. Matthijs van den Adel
Klaus-Michael Geiger
Dr. Hans Jürgen Niehaus
Robert M. Stein
Generally, the net proceeds from each issue of Instruments will be applied by
WestLB for its general corporate purposes, which include making a profit and
hedging certain risks.
If, in the case of Instruments (i) which have a minimum denomination of less
than Euro 50,000 (or its equivalent in other currencies, calculated as described in
the Programme Agreement), or (ii) are derivative securities within the meaning
of Article 15 of the Commission Regulation (EC) no. 809/2004, there is a
particular identified use of proceeds, this will be set out in the relevant Final
Terms, together with the estimated net proceeds.
For further details in relation to WestLB see the section entitled "Description of the Issuer" and commencing on page
240.
INFORMATION RELATING TO THE TERMS AND CONDITIONS OF INSTRUMENTS
The information provided in this subsection is applicable to Notes and to Pfandbriefe unless (i) any references are
explicitly made to Notes (and not to Instruments), or (ii) any information provided in relation to Pfandbriefe in the
subsection entitled "Description of the Debt Issuance Programme – Information Relating to the Terms and
Conditions of Pfandbriefe" is not consistent with the information set out in this subsection. In the case of any such
inconsistency, the information set out in the subsection entitled "Description of the Debt Issuance Programme –
Information Relating to the Terms and Conditions of Pfandbriefe" shall apply to Pfandbriefe in bearer or in registered
form.
Terms and Conditions of the
Instruments:
Final Terms (including, in the case of Index Linked Instruments or Equity
Linked Instruments or Credit Linked Instruments only, the relevant schedule to
be attached to the Final Terms) will be prepared in respect of each Tranche of
Instruments, supplementing or modifying the terms and conditions of the
Instruments set out in the section entitled "Terms and Conditions of the
Instruments" and commencing on page 63, and/or (in the case of Index Linked
Instruments or Equity Linked Instruments only) the section entitled
"Supplemental Terms and Conditions of the Instruments in Relation to Index
Linked Interest Instruments, Equity Linked Interest Instruments, Index Linked
Redemption Instruments or Equity Linked Redemption Instruments" and
commencing on page 174, and/or (in the case of Credit Linked Instruments
only) the section entitled Supplemental Terms and Conditions of the Instruments
in Relation to Credit Linked Instruments" and commencing on page 199. If the
relevant Final Terms specify, however, that (in the case of Instruments other
than Index Linked Instruments or Equity Linked Instruments or Credit Linked
Instruments) integrated conditions shall apply to the Instruments, such
integrated conditions will be attached to the relevant Final Terms and replace
the terms and conditions of the Instruments set out in the section entitled "Terms
and Conditions of the Instruments" and commencing on page 63, as
supplemented or modified by the relevant Final Terms. The terms and
conditions of the Instruments (other than Index Linked Instruments or Equity
Linked Instruments or Credit Linked Instruments) and the relevant Final Terms
will be either in the German or the English language, as may be agreed between
the Issuer and the relevant Dealer. The terms and conditions of Index Linked
Instruments or Equity Linked Instruments or Credit Linked Instruments and the
16